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Bistra I Veleva1, Victor G Chel1,2* and Wilco P Achterberg1,2Abstract
Background: The Dutch Health Council advises a standard daily vitamin D supplementation of 800 IU (20 mcg) for
persons aged ≥ 70 years, with a target 25(OH)D serum concentration of ≥ 50 nmol/l. This recommendation is in
line with advice from the Institute of Medicine (IOM) (2011) and the Expert Working Group on vitamin D (2012). A
target 25(OH)D serum concentration of ≥ 75 nmol/l is also recommended in the literature. It is unknown whether
this advice, initially designed for healthy adults/elderly, will lead to vitamin D sufficiency in the large majority of
nursing home residents, taking into account the frailty of this population.
Methods: Cross-sectional patient file study. Participants were 71 psychogeriatric nursing home residents (25 males,
46 females) with a mean age of 83 (SD 7) years using cholecalciferol capsules (5600 IU) once a week, or cholecalciferol
drops (50,000 IU/ml) 3 drops a week (7500 IU), for at least 3 months. Main outcome measure was serum 25(OH)D level
after supplementation.
Results: Of all participants, 19 used cholecaliferol drops and 52 used cholecaliferol capsules. In total, mean serum 25
(OH)D was 77 (SD 30) nmol/L and 55 residents (78%) were vitamin D sufficient. Among capsule users, mean serum 25
(OH)D was 90 (SD 22) nmol/L and 49 (94%) were vitamin D sufficient. Among users of drops, mean serum 25(OH)D
was 41 (SD 8) nmol/L and 6 (32%) were vitamin D sufficient.
Conclusion: In most of these residents, vitamin D supplementation once a week with cholecalciferol capsules
containing 5600 IU (equivalent to 800 IU daily) resulted in vitamin D sufficiency (serum 25(OH)D ≥ 50 nmol/L). When
choosing a vitamin D preparation for routine supplementation in nursing home residents it should be noted that
major differences may exist in efficacy, even when the various preparations contain the same amount of vitamin D.
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Vitamin D deficiency (serum 25(OH)D < 30 nmol/L) and
insufficiency (serum 25(OH)D > 30 < 50 nmol/L) [1] is
common among older people as a result of reduction in
mobility, time spent outdoors with sun exposure, in-
trinsic skin response to ultraviolet radiation and diet-
ary vitamin D intake [2,3]. In nursing home residents
almost everyone is vitamin D insufficient if vitamin D
is not supplemented [4,5].* Correspondence: v.chel@topaz.nl
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unless otherwise stated.The importance of vitamin D (especially among older
persons) is growing with increasing knowledge on the
numerous biological effects of vitamin D as a promoter
of bone health [6], physical performance [7] and as a
possible modulator in, e.g., cardiovascular disease [8,9],
diabetes [10] and cancer [11]. In nursing homes, vitamin
D supplementation is increasingly being considered as
an indicator and standard for responsible care.
A consensus has not been reached yet among vitamin
D researchers on the optimal 25(OH)D concentrations.
The Endocrine Society clinical practice guidelines (2011)
[12] recommend a target 25(OH)D serum concentration
of ≥ 75 nmol/l with a daily vitamin D requirement of
1,500 -2,000 IU for persons aged ≥ 70 years.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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vitamin D supplementation of 800 IU (20 mcg) for per-
sons aged ≥ 70 years, with a target 25(OH)D serum
concentration of ≥ 50 nmol/l [13]. This recommendation
is in line with advice from the Institute of Medicine
(IOM) (2011) [14] and the Expert Working Group on
vitamin D (2012) [15].
However, it is unknown whether this advice, initially
designed for healthy adults/elderly, will lead to vitamin
D sufficiency in the large majority of nursing home resi-
dents, taking into account the frailty of this population
with multiple comorbidities, polypharmacy, and depend-
ency on basic activities of daily living. One study in
Dutch nursing home residents, investigating the effect of
equivalent oral doses of cholecalciferol 600 IU/day,
4200 IE/week and 18,000 IU/month on vitamin D status
showed that, at 4 months, the percentage of patients
with serum 25(OH)D < 50 nmol/L was 10.9% and 10.6%
in the daily and weekly groups of vitamin D supplemen-
tation, respectively [4].
To our knowledge, no cross-sectional study in nursing
home residents has investigated the efficacy of a daily
vitamin D supplementation dose of 800 IU. Therefore,
the present study investigates the prevalence of vitamin D
sufficiency in a psychogeriatric nursing home population,
after use of the recommended daily supplementation dose
of 800 IU cholecalciferol.
Methods
Participants and intervention
A cross-sectional study was carried out in 71 residents of
dementia care units of the nursing home Topaz Overduin
in Katwijk (the Netherlands), using cholecalciferol cap-
sules, once a week 5600 IE or cholecalciferol drops
(50,000 IU/ml), 3 drops a week (7500 IU). The capsules
contained cholecalciferol 100 IE/mg, cellulose microcrys-
talline PH102, magnesium stearate en lactose monohy-
drate (180). Drops were a watery mixture composed of
cholecalciferol concentrate in oil, citric acid monohydrate,
star anise oil, potassium sorbates, polysorbatum 80
(polyoxyethylene sorbitan monooleat), sugar syrup, and
purified water.
The only exclusion criterion was the use of vitamin D
for less than 3 months.
All blood samples were drawn on the same day.
The best parameter for vitamin D status, 25-hydroxyvi-
tamin D [25(OH)D], was measured by a radioimmuno-
assay (25-OH-vitamin D RIA, Diasorin, Stillwater, MN,
USA). The assay has 100% cross reactivity with 25(OH)D2
and 25(OH)D3. Total imprecision (Interassay coefficient
of variation) is 9.4% at 22 nmol/l. SCAL Medical Diag-
nostics (Foundation central primary care laboratory) is
certified by the Dutch Board for Accreditation and partici-
pates in external quality assessment schemes organized bythe Foundation Quality Control Medical Laboratory
Diagnostics.
Ethical approval
Ethical approval was not necessary under Dutch regula-
tions since this study was a retrospective patient file study.
Among all elderly care physicians in the participating
nursing home, drawing blood samples, in order to check
the effects of vitamin D supplementation on individual
serum 25(OH)D levels, is considered to be a quality of
care standard and therefore part of good medical practice.
Therefore, the drawing of blood samples was for clin-
ical purposes and complied with The Dutch Law of
Agreement to Medical Treatment (WGBO), and not as
research that has to comply with the Dutch law on
Medical Research in Humans (WMO), for which ethical
approval is required. Informed consent however is also
necessary for all diagnostic and clinical work under the
WGBO, so patients who did not want their blood samples
taken, could refuse.
Potential factors that influence 25(OH)D concentration
From the patient files, data were collected on factors pos-
sibly influencing a rise in serum 25(OH)D: age, comorbid-
ity, number and sort of medication use (anticonvulsant
medication and corticosteroids were taken into account
because these increase catabolism of 25(OH)D [13]), body
mass index (BMI), sun exposure, Modification of Diet in
Renal Disease (MDRD) as an estimate of the renal func-
tion, and Functional Ambulation Classification (FAC)
scores as an assessment of the mobility, performed by
physiotherapists and physicians. The FAC consists of
five items. Scores range from 0–5 (0 = Nonfunctional
ambulation; 1 = Ambulator-dependent for physical as-
sistance level II; 2 = Ambulator-dependent for physical
assistance level I; 3 = Ambulator-dependent for supervi-
sion; 4 = Ambulator- independent level surfaces only;
and 5 = Ambulator independent) [16].
Comorbidity was expressed as the number of chronic
diseases, taking into account 7 major conditions [17], i.e.
chronic obstructive pulmonary disease, cardiac disease,
peripheral arterial disease, diabetes mellitus, stroke, cancer
and rheumatoid arthritis/osteoarthritis, and measured by
review of the patients’ medical files. BMI was calculated
as body weight in kg divided by height in m2 and subse-
quently categorized into three groups: underweight
(BMI < 20 kg/m2), normal weight (BMI: 20-25kg/m2)
and overweight (BMI > 25 kg/m2).
Adequate compliance was defined to exist when more
than 80% of the vitamin D medication was ingested.
Statistical analysis
Main outcome measure was serum 25(OH)D level after
supplementation.
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deviation and categorical variables as percentages. We
used Student’s T for comparisons, as well as Chi-squared
test.
A logistic regression analysis was used to assess the
possible predictors of 25(OH)D insufficiency. P-values
were considered significant at a p-value < 0.05. Odds ratios
(OR) and 95% confidence intervals (95% CI) were calcu-
lated to estimate the strength of the association when the
p-value was significant. All analyses were conducted with
SPSS 21 software.
Results
Of the 71 participants with at least 3 months supple-
mentation, 19 used cholecaliferol drops (3 males/16 fe-
males) and 52 used cholecaliferol capsules (14 males/
38 females). In total, mean serum 25(OH)D was 77 (SD
30) nmol/L and 55 residents (78%) were vitamin D
sufficient (Table 1).
Of the 52 capsule users, mean age was 83 (SD 7) years
and mean serum 25(OH)D was 90 (SD 22) nmol/L.
None of this group was vitamin D deficient [25(OH)
D < 30 nmol/L], whereas 3 (6%) were vitamin D insuffi-
cient [25(OH)D <50 nmol/L], 49 (94%) were vitamin D
sufficient [25(OH)D ≥ 50 nmol/L] and 42 of this group
(80%) had serum 25(OH)D levels > 75 nmol/L.
Of the 19 drop users, mean age was 82 (SD 8) years
and mean serum 25(OH)D level was 41 (SD 18) nmol/L.
In this group, 6 (32%) were vitamin D deficient [25(OH)
D < 30 nmol/L], 7 (37%) were vitamin D insufficient [25
(OH)D <50 nmol/L], 6 (31%) were vitamin D sufficient
[25(OH)D ≥50 nmol/L], and 1 (5%) had serum 25(OH)D
levels > 75 nmol/L.
Among drops user, all 19 (100%) participants were
compliant. Among capsule users 50 (96%) were compliant
and 2 (4%) were not.
Because of the lower serum concentration of 25(OH)D
in the group of drop users we used Student’s T for com-
parisons as well as Chi-squared test to compare the basic
characteristics of the two groups that can influence the 25
(OH)D concentration. A significant difference was estab-
lished in the BMI between the two groups (p 0.01) with a
higher number of persons with overweight in the group of
the drop users. Subsequently we carried out a bivariate
analysis with the serum vitamin D concentration (pa-
tients divided in two groups 25(OH)D < 50 nmol/l and
25(OH)D ≥ 50 nmol/l) as dependent variable to control
for potential confounders that can influence vitamin D
concentration.
The use of cholecalciferol drops was a strong predictor
of 25(OH)D insufficiency (OR 35.3; p < 0.0001; 95% CI
7.7-160.9) (Table 2).
In the total study population, residents with 25(OH)D
serum levels ≥50 nmol/L were more likely to have lesscomorbidity: i.e. ≤ 2 chronic somatic diseases registered
(p = 0.02; OR 4.0; CI 1.2-13.0). However, this correlation
was not significant among drop users. Among capsule
users, the number of vitamin D insufficient subjects was
too low (<5) to examine this correlation.
In both groups, no association was found between the
other possible confounders (gender, age, BMI, renal func-
tion, sun exposure, number and kind of medication and
mobility status) and vitamin D insufficiency.
Discussion
Vitamin D supplementation that may be needed to
achieve optimal concentration of 25(OH)D in all popu-
lations is not established. Studies suggest that 700 to
1000 IU vitamin D per day may be enough to bring 50%
of the younger and older adults up to 75–100 nmol/l
[18-20]. In our study a supplementation of 5600 IU vitamin
D once a week by capsules brings 80% of the older adults
to serum 25(OH)D higher than 75 nmol/l.
A strength of the present study is that it is the first to
demonstrate that a population-based approach in vitamin
D supplementation strategy is feasible, even in a popula-
tion of fragile institutionalized older people.
However, because it is a single-site study with a rela-
tively small number of patients the external validity is
limited. The study was conducted in Dutch nursing
home residents and recommendations are for this popu-
lation. Reproduction of the study in multiple sites and
countries is therefore warranted.
The present study reveals a striking difference between
the efficacy of drops and capsules in reaching vitamin D
sufficiency in a psychogeriatric nursing home population.
In capsules users only 3 of 52 subjects (6%) were
vitamin D insufficient; 2 of these participants had low
medication compliance because of unwillingness to take
the medication (presumably related to their cognitive
decline). The third insufficient resident had a history
of recurrent bladder carcinoma, long carcinoma and
radiotherapy, cardiac disease and chronic renal failure.
Among users of drops, no less than 13 of 19 subjects
(69%) had insufficient 25(OH) serum levels. Possible
reasons for this discrepancy were further investigated.
Indeed we didn’t have the baseline 25(OH)D levels of
our patients before the supplementation. In a previous
study conducted in Netherlands, vitamin D baseline level
was found to be insufficient in 98% of the nursing home
residents [4]. It is also obvious in our study that the drop
users have a longer duration of vitamin D supplementa-
tion than capsule users (p < 0.0001) and no one of the
drop users receives the supplementation shorter than
one year.
Compliance with the ingestion of drops was 100% in
all participants; drops were administered by spoon with
apple sauce, or in a small quantity of tea or water. In no
Table 1 Characteristics of 71 patients with vitamin D supplementation
Total group Supplementation by capsules Supplementation by drops P
Subjects (females/males), n 71 (46/25) 52 (38/14) 19 (16/3) 0.5
Age in years, mean (SD) 83 (7) 83 (7) 82 (8) 0.4
Serum 25(OH)D1 nmol/L, mean (SD) 77 (30) 90 (22) 41 (18) <0.001
Ser. 25(OH)D in residents, % (n)
≥75 61 (43) 80 (42) 5 (1)
≥50-74.9 17 (12) 14 (7) 26 (5)
30-49.9 nmol/L 14 (10) 6 (3) 37 (7)
< 30 nmol/L 8 (6) 0 (0) 32 (6)
Duration supplementation% (n)
<0.001
3-6 months 24 (17) 33 (17) 0 (0)
12-18 months 45 (32) 60 (31) 5 (1)
>18 months 31 (22) 7 (4) 95 (18)
Subjects with sunlight exposure >1 × week% (n) 61 (43) 44 (23) 74 (14) 0.2
Number of medications% (n)
0.9<5 73 (52) 73 (38) 74 (14)
>5 27 (19) 27 (14) 26 (5)
Medication influencing 25(OH)D 15 (11) 15 (8) 15 (3)
0.8- anticonvulsants 1 (1) 2 (1) 0
- corticosteroids 14 (10) 13 (7) 15 (3)
FAC2, % (n)
0.3
0 39 (27) 43 (23) 21 (4)
1 11 (8) 10 (5) 16 (3)
2 11 (8) 10 (5) 16 (3)
3 14 (10) 10 (5) 26 (5)
4 21 (15) 23 (12) 16 (3)
5 4 (3) 4 (2) 5 (1)
BMI3, % (n)
0.01
<20 underweight 55 (39) 60 (31) 42 (8)
20-25 healthy weight 34 (24) 34 (18) 32 (6)
>25 overweight 11 (8) 6 (3) 26 (5)
MDRD4, % (n)
0.7<60 31 (22) 33 (17) 26 (5)
>60 69 (49) 67 (35) 74 (14)
Chronic disease5, % (n)
0.6≤2 73 (52) 73 (38) 74 (14)
>2 27 (19) 27 (14) 26 (5)
Values are mean (SD) or number (percentage).
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were stored as specified by the pharmacist; the pharma-
cist also confirmed that 3 drops do in fact contain
7500 IU of cholecalciferol. Drops were a watery mixture
composed of cholecalciferol concentrate in oil, citric acid
monohydrate, star anise oil, potassium sorbates, polysor-
batum 80 (polyoxyethylene sorbitan monooleat), sugar
syrup, and purified water, which appears to have betterbioavailability than oily formulations [21]. In the nursing
home Topaz Overduin the method used for supplementing
vitamin D has changed over time from drops to capsules;
this means that there was no specific reason why any
resident should still be using drops.
The nursing staff was asked about the way drops were
administered. They reported this occurred in 3 ways,
depending on the nurse’s personal choice: 1) 3 drops were
Table 2 Predictors of vitamin D insufficiency in patients with dementia with Vitamin D supplementation: binary
logistic regression analyses
25(OH)D1 < 50 nmol/L 25(OH)D ≥50 nmol/L P-value OR 95% CI
N 16 55
Gender, % (n) 0.9
Male 25 (12) 23 (13)
Female 75 (4) 76 (42)
Age in years, mean (SD) 83 (SD 8) 83 (SD 7) 0.9
Subjects with sunlight exposure >1x/week, % (n) 25 (4) 44 (24) 0.1
Drops/capsules, % (n) <0.0001 35.3 7.7-160.9
- drop users 81 (13) 11 (6)
- capsule users 19 (3) 89 (49)
No. of medications, % (n) 0.8
<5 75 (12) 72 (40)
>5 25 (4) 27 (15)
FAC2, % (n) 0.3
0 25 (4) 42 (23)
1 6 (1) 13 (7)
2 19 (3) 9 (5)
3 31 (5) 9 (5)
4 13 (2) 24 (13)
5 6 (1) 4 (2)
BMI3, (n) 0.3
<20 underweight 56 (9) 55 (30)
20-25 healthy weight 25 (4) 36 (20)
>25 overweight 19 (3) 9 (5)
MDRD4, % (n) 0.6
<60 37 (6) 29 (16)
>60 62 (10) 71 (39)
Comorbidity5, % (n) 0.02 0.2 0.07-0.8
≤ 2 diseases 50 (8) 80 (44)
>2 diseases 50 (8) 20 (11)
125(OH)D −25-hydroxyvitamin D.
2FAC - Functional Ambulation Classification.
3BMI - Body Mass Index.
4MDRD - Modification of Diet in Renal Disease.
5Chronic diseases from seven majors: chronic obstructive pulmonary disease, cardiac disease, peripheral arterial disease, stroke, diabetes mellitus, rheumatoid
arthritis/osteoarthritis and cancer.
Veleva et al. BMC Geriatrics 2014, 14:103 Page 5 of 7
http://www.biomedcentral.com/1471-2318/14/103administered directly from the drop container, 2) 3 drops
were given using a 1-ml syringe (delivered standard by the
pharmacist with the drop container and the instruction
that 0.11 ml be taken in case of syringe use), or 3) 0.11 ml
was administrated with the 1-ml syringe. Over time, each
resident received the drops in these different ways, implying
that there was no set procedure of administration for any
particular group.
A literature search for confounders in attaining accuracy
and precision of delivery from containers with oral drops,
yielded several pediatric and ophthalmologic studies[22-24]. Interestingly one of these studies, assessing
the dose uniformity of samples delivered from pediatric
oral droppers, discovered that the key factor in achieving
satisfactory dispensing is the position of the dropper -
which has to be held vertically [22].
In our nursing home, the two other routes of adminis-
tration of drops are also susceptible to dosage errors, i.e.
accurate titration of 0.11 ml cholecalciferol with a 1-ml
syringe is practically impossible; also, drops given via a
syringe have a different volume than drops given with
the container. Since the nursing staff of our nursing
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tration of drops, this might be an explanation for the
discrepancy found. Because dosage errors are possible
when administering small volumes of solutions, nursing
staff should be guided on the correct method of delivery.
Conclusion
Vitamin D supplementation using cholecalciferol capsules
containing 5600 IU, once a week (equal to 800 IU
daily) will result in vitamin D sufficiency (serum 25
(OH)D ≥ 50 nmol/L), regardless of gender, age, BMI,
renal function, sun exposure, comorbidity, medication
and mobility status. When choosing a vitamin D prep-
aration for routine supplementation for nursing home
residents, it is important to note that major differences in
efficacy may exist between various types of preparations,
even when they apparently contain the same amount of
vitamin D. This raises the issue of standardization of drops
administration for the purpose of avoiding failure in the
meeting of recommended daily needs of vitamin D.
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